Annette Reichardt

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Journal: British journal of cancer

Published: February 21, 2024

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 30, 2022

Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study.

Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study.

Journal: Infection

Published: December 20, 2022

Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.

Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.

Journal: Vaccine

Published: August 10, 2022

Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.

Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.

Journal: ESC heart failure

Published: April 27, 2022

Fibrinogen-like protein 2 in gastrointestinal stromal tumour.

Fibrinogen-like protein 2 in gastrointestinal stromal tumour.

Journal: Journal of cellular and molecular medicine

Published: August 26, 2021

Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.

Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.

Journal: Oncology research and treatment

Published: August 26, 2020

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.

Journal: JAMA oncology

Published: May 30, 2020

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Journal: JAMA oncology

Published: March 24, 2017

Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 07, 2016

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 04, 2015

Gastrointestinal stromal tumors (GIST)

Gastrointestinal stromal tumors (GIST)

Journal: Deutsche medizinische Wochenschrift (1946)

Published: September 26, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026